Cargando…

Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity

This study aimed to determine the short- and/or long-term outcomes of levothyroxine replacement therapy in extremely low birth weight (ELBW) infants with transient hypothyroxinemia of prematurity (THOP). The medical records of 335 ELBW infants with THOP were reviewed retrospectively to identify whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Shin Ae, Chang, Yun Sil, Yang, Misun, Ahn, So Yoon, Sung, Se In, Cho, Hee-seung, Park, Won Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188355/ https://www.ncbi.nlm.nih.gov/pubmed/35690687 http://dx.doi.org/10.1038/s41598-022-13927-2

Ejemplares similares

Incidence and severity of transient hypothyroxinaemia of prematurity associated with survival without composite morbidities in extremely low birth weight infants
por: Yoon, Shin Ae, et al.
Publicado: (2019)

An Alternative Route of Treatment in Transient Hypothyroxinemia of Prematurity: Rectal Administration of Levothyroxine
por: Tunçel, Duygu, et al.
Publicado: (2023)

Hypothyroxinemia in extremely low birth weight infants
por: Ghirri, Paolo, et al.
Publicado: (2015)

Mortality and Morbidities according to Time of Birth in Extremely Low Birth Weight Infants
por: Yang, Misun, et al.
Publicado: (2021)

Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants
por: Yoon, Shin Ae, et al.
Publicado: (2019)

The factors associated with transient hypothyroxinemia of prematurity
por: Yilmaz, Aslan, et al.
Publicado: (2021)

Permissive Hyperglycemia in Extremely Low Birth Weight Infants
por: Yoo, Hye Soo, et al.
Publicado: (2013)

Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants
por: Tan, Lay Ong, et al.
Publicado: (2019)

Permissive Hypotension in Extremely Low Birth Weight Infants (≤1000 gm)
por: Ahn, So Yoon, et al.
Publicado: (2012)

The prevalence of hypothyroxinemia in premature newborns
por: Stawerska, Renata, et al.
Publicado: (2022)

Correction: Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants
por: Tan, Lay Ong, et al.
Publicado: (2019)

Predicting mortality in extremely low birth weight infants: Comparison between gestational age, birth weight, Apgar score, CRIB II score, initial and lowest serum albumin levels
por: Park, Jae Hyun, et al.
Publicado: (2018)

Effect of Levothyroxine on Pregnancy Outcomes in Pregnant Women With Hypothyroxinemia: An Interventional Study
por: Li, Guohua, et al.
Publicado: (2022)

Conservative Non-intervention Approach for Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants
por: Sung, Se In, et al.
Publicado: (2020)

Prevention of Cytomegalovirus Transmission via Breast Milk in Extremely Low Birth Weight Infants
por: Yoo, Hye Soo, et al.
Publicado: (2015)

Associations of Respiratory Distress Syndrome Severity and Other Factors With Transient Hypothyroxinemia of Prematurity
por: Dursun, Mesut, et al.
Publicado: (2021)

Transient hypothyroxinemia of prematurity and its risk factors in an extramural neonatal intensive care unit
por: Rai, Ruchi, et al.
Publicado: (2021)

Idiopathic severe hypermagnesemia in an extremely low birth weight infant on the first day of life
por: Hyun, Hye Sun, et al.
Publicado: (2011)

The Impact of Surgical Intervention on Neurodevelopmental Outcomes in Very Low Birth Weight Infants: a Nationwide Cohort Study in Korea
por: Sung, Se In, et al.
Publicado: (2019)

Early Levothyroxine Treatment for Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy: The St Carlos Gestational and Thyroid Protocol
por: Runkle, Isabelle, et al.
Publicado: (2021)

Clinical indicators that influence a clinician’s decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia
por: Yilmaz, Aslan, et al.
Publicado: (2023)

Correction: Clinical indicators that influence a clinician’s decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia
por: Yilmaz, Aslan, et al.
Publicado: (2023)

Factors Affecting Metabolic Bone Disease of Prematurity: Is Hypothyroxinemia Included?
por: Dursun, Mesut, et al.
Publicado: (2022)

Conservative Management of Patent Ductus Arteriosus Is Feasible in the Peri-Viable Infants at 22–25 Gestational Weeks
por: Yang, Misun, et al.
Publicado: (2022)

Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams
por: Chun, Jiyoung, et al.
Publicado: (2017)

Antenatal Magnesium Sulfate Is Not Associated With Improved Long-Term Neurodevelopment and Growth in Very Low Birth Weight Infants
por: Jeon, Ga Won, et al.
Publicado: (2023)

Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation
por: Sung, Se In, et al.
Publicado: (2019)

Hypothyroxinemia: Zoeller's Response
por: Zoeller, RT
Publicado: (2004)

Incidence and risk factors for retinopathy of prematurity in premature, extremely low birth weight and extremely low gestational age infants
por: Yucel, Ozlem Eski, et al.
Publicado: (2022)

Maximum Vasoactive-Inotropic Score and Mortality in Extremely Premature, Extremely Low Birth Weight Infants
por: Aziz, Khyzer B., et al.
Publicado: (2021)

Changes in Serum Creatinine Levels and Natural Evolution of Acute Kidney Injury with Conservative Management of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants at 23–26 Weeks of Gestation
por: Seo, Eun Seop, et al.
Publicado: (2020)

Transcutaneous CO(2) Monitoring in Extremely Low Birth Weight Premature Infants
por: Borenstein-Levin, Liron, et al.
Publicado: (2023)

Trends in Overall Mortality, and Timing and Cause of Death among Extremely Preterm Infants near the Limit of Viability
por: Park, Jae Hyun, et al.
Publicado: (2017)

Continuous Renal Replacement Therapy in Preterm Infants
por: Noh, Eu Seon, et al.
Publicado: (2019)

Increased risk of refeeding syndrome–like hypophosphatemia with high initial amino acid intake in small-for-gestational-age, extremely-low-birthweight infants
por: Sung, Se In, et al.
Publicado: (2019)

Survival rate dependent variations in retinopathy of prematurity treatment rates in very low birth weight infants
por: Park, Jae Hyun, et al.
Publicado: (2020)

Trends in Survival and Incidence of Bronchopulmonary Dysplasia in Extremely Preterm Infants at 23–26 Weeks Gestation
por: Kim, Jin Kyu, et al.
Publicado: (2016)

Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose‐Escalation Clinical Trial
por: Ahn, So Yoon, et al.
Publicado: (2018)

The Incidence and Risk Factors of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants in Turkey
por: Celebi, Ali Riza Cenk, et al.
Publicado: (2014)

The Efficacy of Clinical Strategies to Reduce Nosocomial Sepsis in Extremely Low Birth Weight Infants
por: Hwang, Jong Hee, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_vd9ofgusgvqrc16ttgoqp97ti5